Cerilon GTL ND Enters Into Diesel Offtake Agreement for its North Dakota Gas-to-Liquids Project
Calgary, Alberta--(Newsfile Corp. - February 11, 2026) - Cerilon GTL ND Inc. ("Cerilon") is pleased to announce the signing of a definitive offtake agreement with a large North American fuel supply and logistics provider ("Offtaker") for ultra-low-sulfur diesel from its gas-to-liquids (GTL) project under development in Williams County, North Dakota. Under the agreement, the Offtaker will purchase all of the diesel output from Cerilon's North Dakota facility, subject to customary terms
Technologies, Produits chimiques, Énergie, Énergies de substitution
2026-02-11 10:00 AM EST | Cerilon Inc.
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended November 30, 2025 (Q1). The Company generated revenues of $2.7 million during this period, driven by continued market adoption of its flagship product, DirectI
Technologies, Produits chimiques, Pharmaceutique
2026-01-30 7:28 PM EST | Telescope Innovations Corp.
Telescope Innovations Expands Lithium Development Infrastructure and Achieves Key Material Validation Milestones
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a leader in Physical AI, Self-Driving Laboratories, and other enabling technology to support autonomous laboratory infrastructure. The Company is pleased to provide an update on the progress of its lithium processing portfolio. Our focus remains on securing a sustainable, on-shore supply of critical battery materials t
Technologies, Produits chimiques, Pharmaceutique
2026-01-27 8:00 AM EST | Telescope Innovations Corp.
Telescope Innovations Plans Expansion of DirectInject-LC(TM) Technology Ecosystem to Fuel the Physical AI Revolution
Vancouver, British Columbia--(Newsfile Corp. - January 20, 2026) - Telescope Innovations Corp., (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), is a leader in Physical AI, Self-Driving Laboratories, and enabling technology supporting autonomous laboratory infrastructure. The Company is pleased to provide a look at its planned 2026 technology development pipeline, which aligns with its Self-Driving Lab (SDL) architecture for autonomous chemistry R&D. Buildin
Technologies, Produits chimiques, Pharmaceutique
2026-01-20 8:00 AM EST | Telescope Innovations Corp.
Telescope Innovations Outlines Global Market Opportunity for Self-Driving Labs and the Rising Adoption of Physical AI
Vancouver, British Columbia--(Newsfile Corp. - January 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to provide a strategic update regarding the accelerating commercial adoption of Self-Driving Labs (SDLs) and the global expansion of Physical AI. This update follows the Company's recent successful deployment of a
Technologies, Produits chimiques, Pharmaceutique
2026-01-05 8:00 AM EST | Telescope Innovations Corp.
Telescope Grants Stock Options, RSUs and Settles Debt with Shares
Vancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries announces that it has authorized the grant of incentive stock options (the "Options"), restricted share units (the "RSUs") as well as the issuance of common shares to settle outstanding fees owed to its
Technologies, Produits chimiques, Pharmaceutique
2025-12-31 8:00 AM EST | Telescope Innovations Corp.
Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, reports financial results for the fiscal year ended August 31, 2025. The Company generated revenues of $5.8 million during this period, with an Adjusted EBITDA loss of $402K (Figure 1). Telescope continues
Technologies, Produits chimiques, Pharmaceutique
2025-12-23 8:00 PM EST | Telescope Innovations Corp.